-
1دورية أكاديمية
المؤلفون: Maximilian Ell, Mai Thu Bui, Seyda Kigili, Günther Zeck, Sonia Prado-López
المصدر: Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
مصطلحات موضوعية: CMOS microelectrode array, cell adhesion noise spectroscopy, colorectal cancer cells, human dermal fibroblasts, anti-cancer therapeutics, Biotechnology, TP248.13-248.65
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fbioe.2024.1385730/fullTest; https://doaj.org/toc/2296-4185Test
-
2رسالة جامعية
المؤلفون: Kefala Stavridi, Antonia
المساهمون: Blundell, Tom L.
مصطلحات موضوعية: anti-cancer therapeutics, cryo-EM, DNA repair, fragment-based drug discovery, NHEJ
-
3دورية أكاديمية
المؤلفون: Nojoud Al-Ansari, Samson Mathews Samuel, Dietrich Büsselberg
المصدر: Biomolecules, Vol 14, Iss 2, p 145 (2024)
مصطلحات موضوعية: anti-cancer therapeutics, apoptosis, bone cancer, melatonin, osteosarcoma, Microbiology, QR1-502
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Liya Li, Wangxiao He, Weiming You, Jin Yan, Wenjia Liu
المصدر: Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-15 (2022)
مصطلحات موضوعية: miRNA clinical translation, Nuclear acid therapeutics, Nanoengineering, Infinite covalent polymer, Anti-cancer therapeutics, Biotechnology, TP248.13-248.65, Medical technology, R855-855.5
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1477-3155Test
-
5دورية أكاديمية
المؤلفون: Natasha Salame, Katharine Fooks, Nehme El-Hachem, Jean-Pierre Bikorimana, François E. Mercier, Moutih Rafei
المصدر: Frontiers in Pharmacology, Vol 13 (2022)
مصطلحات موضوعية: HTS screening, fluorescence-based assay, immunomodulatory compounds, anti-cancer therapeutics, transcriptomics, CRISPR-Cas9, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2022.852143/fullTest; https://doaj.org/toc/1663-9812Test
-
6دورية أكاديمية
المؤلفون: Fanfan Zhou, Hong Zhu, Caiyun Fu
المصدر: Frontiers in Pharmacology, Vol 12 (2022)
مصطلحات موضوعية: cancer resistance, targeted therapies, therapeutic development, anti-cancer therapeutics, therapeutic resistance, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2021.816896/fullTest; https://doaj.org/toc/1663-9812Test
-
7دورية أكاديمية
المؤلفون: Mc Elligott, Tony, Rozas, Isabel, Zisterer, Daniela, Hayden, Patrick, Lynam-Lennon, Niamh, Browne, Paul
مصطلحات موضوعية: Anti-cancer therapeutics, Drug discovery, MCL-1, Multiple myeloma, STAT3, Signal transducer and activator of transcription 3, Cancer, APOPTOSIS, Apoptosis and cancer, molecular control, Biology and therapy of myeloma, Blood Cancers, CELL APOPTOSIS, CELL SIGNALING, CHEMOTHERAPY-INDUCED APOPTOSIS, Cancer drug discovery, Cellular and molecular mechanisms regulating and resisting apoptosis, profiling, targeting, INDUCE APOPTOSIS, INDUCED APOPTOSIS, MULTIPLE-MYELOMA, MYELOMA, Molecular mechanisms underlying apoptosis & cell cycle, Multidisciplinary approach to drug discovery and development, pre-clinical assessment
العلاقة: Life Sciences; 290; Rebecca Amet, Viola Previtali, Helene B. Mihigo, Emily Sheridan, Sarah Brophy, Nadhim Kamil Hante, Maria Jose Santos-Martinez, Patrick J. Hayden, Paul V. Browne, Isabel Rozas, Anthony M. McElligott, Daniela M. Zisterer, A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma, Life Sciences, 290, 2022; Y; http://hdl.handle.net/2262/97864Test; http://people.tcd.ie/mcelligaTest; http://people.tcd.ie/brownpvTest; http://people.tcd.ie/rozasiTest; http://people.tcd.ie/lynamlnTest; http://people.tcd.ie/dzistrerTest; http://people.tcd.ie/haydenpTest; 235982; http://dx.doi.org/10.1016/j.lfs.2021.120236Test; orcid:0000-0003-3276-1341
الإتاحة: https://doi.org/10.1016/j.lfs.2021.120236Test
http://hdl.handle.net/2262/97864Test
http://people.tcd.ie/mcelligaTest
http://people.tcd.ie/brownpvTest
http://people.tcd.ie/rozasiTest
http://people.tcd.ie/lynamlnTest
http://people.tcd.ie/dzistrerTest
http://people.tcd.ie/haydenpTest -
8دورية أكاديمية
المؤلفون: Liya Li (1698874), Wangxiao He (11905210), Weiming You (4451563), Jin Yan (193119), Wenjia Liu (118146)
مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Cell Biology, Genetics, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Hematology, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, miRNA clinical translation, Nuclear acid therapeutics, Nanoengineering, Infinite covalent polymer, Anti-cancer therapeutics
-
9دورية أكاديمية
المؤلفون: Hsieh, M.-H., Hsu, J.-S., Ergun, Y., Chou, G.-L., Li, T.-K., Teng, S.-C., Zencir, Sevil
مصطلحات موضوعية: Anti-cancer therapeutics, Alternative lengthening of telomere, DNA topoisomerase II, Ellipticine derivatives, antineoplastic agent, DNA topoisomerase (ATP hydrolysing), Cell Line, ellipticine, ellipticine derivative, icrf 93, telomerase inhibitor, unclassified drug, gyrase inhibitor, telomerase, ALT cell line, Article, cell viability, comet assay, controlled study, cytotoxicity, DNA strand breakage, drug selectivity, female, fluorescence in situ hybridization, human, human cell, immunofluorescence, MTS assay, phenotype, priority journal
العلاقة: Journal of Cancer Research and Clinical Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11499/37105Test; https://doi.org/10.1007/s00432-020-03213-xTest; 146; 1671; 1676; 2-s2.0-85083865035; WOS:000528431700002
-
10دورية أكاديمية
المؤلفون: Gavande, Navnath S, VanderVere-Carozza, Pamela S, Pawelczak, Katherine S, Mendoza-Munoz, Pamela, Vernon, Tyler L, Hanakahi, Leslyn A, Summerlin, Matthew, Dynlacht, Joseph R, Farmer, Annabelle H, Sears, Catherine R, Nasrallah, Nawar Al, Garrett, Joy, Turchi, John J
المساهمون: Medicine, School of Medicine
المصدر: Publisher
مصطلحات موضوعية: protein kinase, DNA-PK, anti-cancer therapeutics
وصف الملف: application/pdf
العلاقة: Nucleic Acids Research; Gavande, N. S., VanderVere-Carozza, P. S., Pawelczak, K. S., Mendoza-Munoz, P., Vernon, T. L., Hanakahi, L. A., Summerlin, M., Dynlacht, J. R., Farmer, A. H., Sears, C. R., Nasrallah, N. A., Garrett, J., & Turchi, J. J. (2020). Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction. Nucleic Acids Research, 48(20), 11536–11550. https://doi.org/10.1093/nar/gkaa934Test; 0305-1048, 1362-4962; https://hdl.handle.net/1805/27306Test